跳至主要内容
临床试验/NCT05842564
NCT05842564尚未招募不适用

Autophagic Activity Characterization in Pediatric Crohn's Disease

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年1月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
70
试验地点
2
主要终点
Quantification of autophagic flux by western blot.

研究概览

简要总结

Crohn's disease is a multifactorial complex disease resulting in a between microbiota and immune system. Indeed, GWAS (Genome-Wide Association Studies) association study pinpointed polymorphisms as genes susceptibility on more than 200 loci. Among them genes coding for proteins involved in autophagy machinery (i.e: ATG16L1, IRGM et NDP52). Autophagy is a ubiquitous intracellular mechanism mandatory for protein and microorganism recycling.

So far, the role of autophagy in gut inflammation and intestinal homeostasis in Crohn's disease patients is partially understand. Then, investigators plan to evaluate, on native cells, the autophagic flux in pediatric patients suffering of a Crohn's disease compare to controls.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • For Crohn's Disease group :
  • Age between 6 and 17 inclusive
  • Patients with a weight > 25 kg at the time of inclusion
  • Patients with Crohn's disease requiring ileocolonoscopy (diagnosis or follow-up)
  • Mild to severe Crohn's disease consistent with PCDAI disease activity score
  • Patients on nutritional therapy (Modulen/Modulife), corticosteroids, salicylic derivatives, immunosuppressants, biotherapies (anti-TNF, vedolizumab and ustekinumab) or without treatment
  • Consent form signed by the patient or the holder(s) of parental authority.
  • Affiliation to a social security scheme or beneficiaries of a similar scheme.
  • For Control group:
  • Between 6 and 17 years old included
  • Presenting a weight > 25 kg at the time of inclusion
  • Without a diagnosis of Crohn's disease
  • Requiring evaluation by ileoendoscopy
  • Consent form signed by the patient or the holder(s) of parental authority.
  • Affiliation to a social security scheme or beneficiaries of a similar scheme.

排除标准

  • Refusal to participate in the protocol
  • Intercurrent infection
  • Ongoing antibiotic treatment
  • Patient involved in another interventional study protocol including an exclusion period still in progress at pre-inclusion
  • Pregnant, parturient or breastfeeding women (on questioning)
  • Persons deprived of their liberty by a judicial or administrative decision
  • Persons subject to psychiatric care
  • Persons admitted to a health or social establishment for purposes other than research

结局指标

主要结局

Quantification of autophagic flux by western blot.

时间窗: 1 day (during hospitalization for ileocolonoscopy)

LC3II/LC3I will be measured by western blot after booking the autophagic flux at different time point.

次要结局

  • Incidence of autophagic polymorphisms in pediatric Crohn's disease population(1 day (during hospitalization for ileocolonoscopy))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验